ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,184, issued on July 29, was assigned to BIOVERSYS AG (Basel, Switzerland).
"Antibiotic combination therapies" was invented by Vincent Trebosc (Rixheim, France), Christian Kemmer (Riehen, Switzerland), Glenn E. Dale (Basel, Switzerland), Sergio Lociuro (Basel, Switzerland) and Marc Gitzinger (Laufenburg, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides antibiotic combination therapies for treating an A. baumannii infection in a subject. The combination therapies include rifabutin and a second antibiotic, such as colistin and cefiderocol."
The patent was filed on Sept. 12, 2023, under Application No. 18/465,226.
*For...